stockrowAbbott Laboratories
ABT Healthcare Medical Devices
Abbott Laboratories' revenue for fiscal 2025 (year ended December 2025) was $44.3 billion, up 5.67% from fiscal 2024.
- Revenue
- +14.5%
- EPS
- −43.6%
- Free cash flow
- +28.9%
- Total debt
- +140.8%
Quarter to September 2026, against a year earlier
Follow ABT
Alert me
Abbott Laboratories (ABT) Free cash flow margin
Abbott Laboratories's free cash flow margin over the twelve months to 30 September 2026 was 14.0%, down 2.7 percentage points from fiscal 2025 (16.7%). Over the past ten years it has ranged from 9.10% (fiscal 2015) to 20.1% (fiscal 2021); the current reading is higher than 82% of that period. That is above the Medical Devices industry median of −3.88% and in line with the Healthcare sector median of 0.00%.
Free cash flow margin, annual
Embed this chart
Annual newest first
| Period | Free cash flow margin | Change (points) |
|---|---|---|
| FY2025 | 16.7% | 1.54 |
| FY2024 | 15.1% | 2.53 |
| FY2023 | 12.6% | (5.27) |
| FY2022 | 17.9% | (2.20) |
| FY2021 | 20.1% | 3.54 |
| FY2020 | 16.5% | 2.44 |
| FY2019 | 14.1% | (1.94) |
| FY2018 | 16.0% | (0.15) |
| FY2017 | 16.2% | 6.21 |
| FY2016 | 9.98% | 0.88 |
Against its own ten years
Free cash flow margin against peers
| Company | Free cash flow margin |
|---|---|
| DXCM DexCom, Inc. compare | 21.5% |
| EW Edwards Lifesciences Corporation compare | 21.3% |
| STE STERIS plc compare | 20.9% |
| SYK Stryker Corporation compare | 16.8% |
| MDT Medtronic PLC compare | 16.3% |
| BSX Boston Scientific Corporation compare | 15.8% |
| PHG Koninklijke Philips N.V. compare | 10.3% |
| GEHC GE HealthCare Technologies Inc. compare | 8.73% |
| ABT Abbott Laboratories | 0.00% |
| Medical Devices industry median | −3.88% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Free cash flow margin is
Free Cash Flow Margin tells an investor how much of each sale turns into cash the company keeps after paying for investment in its assets.
(Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)) ÷ Revenue
More on ABT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement